Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1627 results

Is frailty still relevant after 20 years of TAVI?

28 Nov 2022 – From PCR London Valves 2022

Consult this session to gain further knowledge of the frailty syndrome, to understand its relevance in today's patient population and to learn how to measure it using validated tools.

Is frailty still relevant after 20 years of TAVI?

Challenging scenarios: TAV-in-TAV procedures

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover some challenging TAV-in-TAV procedures, and learn more about the key role of imaging during pre-procedural work-up and the potential treatment options after TAVI bioprosthetic valve fracture.

Challenging scenarios: TAV-in-TAV procedures

Challenging scenarios: acute coronary obstruction

28 Nov 2022 – From PCR London Valves 2022

Discover some challenging case of acute coronary obstruction in these presentations, and learn more about the anatomical and procedural factors that predict this complication during TAVI, the available strategies for coronary protection during TAVI, as well as the leaflet laceration techniques to prevent TAVI-induced coronary obstruction.

Challenging scenarios: acute coronary obstruction

Patient-prosthesis mismatch: surgical and transcatheter approaches - LIVE case

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover different surgical and transcatheter approaches:

  • Part 1: Bioprosthesis aortic valve stenosis
    A 73-year-old male, with diabetes, BMI 29, atrial fibrillation, history of SAVR 15 years ago (Perimount 27) presents a symptomatic severe surgical valve stenosis with a preserved LV function.
    During the live time...
Patient-prosthesis mismatch: surgical and transcatheter approaches

Challenging scenarios: bicuspid aortic valves

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the variety of bicuspid aortic valve phenotypes and their impact on procedural outcomes, the pre-procedural planning and optimal procedural technique in this challenging patient cohort, as well as the key considerations for TAVI in younger patients with a bicuspid aortic valve.

Challenging scenarios: bicuspid aortic valves

Challenging scenarios: bioprosthetic valve dysfunction

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the different causes of bioprosthetic valve dysfunction and the best options (surgical, transcatheter or medical) for the management of patients with this kind of dysfunction, as well as to discover how valve design impacts on durability and what the future holds...

Challenging scenarios: bioprosthetic valve dysfunction

Rapid-fire abstracts: Session 6

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: hydrodynamic performance of ACURATE neo2 for valve-in-valve across different surgical bioprostheses, impact of leaflets splitting on coronary access after redo TAVI in failed supra-annular platforms, same-day discharge after TF and alternate access...

Rapid-fire abstracts: Session 6

TAVI challenges: session 2

28 Nov 2022 – From PCR London Valves 2022

Watch this PCR LV 2022 session to learn how to treat TAVI with severe peripheral calcifications, a complex TAVI with extreme tortuous and horizontal aorta, or even TAVI in aortic regurgitation patient after failed attempt with commercial device. 

TAVI challenges: session 2

Rapid-fire abstracts: Session 7

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: contemporary outcome of high surgical risk mitral regurgitation, quantitative flow ratio vs. FFR for coronary functional evaluation in patients undergoing TAVI, videodensitometric quantification of paravalvular leak after implantation of the new Myval-Octacor,...

Rapid-fire abstracts: Session 7

TAVI challenges: session 3

28 Nov 2022 – From PCR London Valves 2022

View a radial access balloon aortic valvuloplasty adapting to the challenge of small arteries, a semi-inflated buddy balloon for percutaneous TAVR in severe calcified bicuspid aortic valve, and long-term outcome of TAVR in mucopolysaccharidosis type I-HS in this PCR LV 2022 session, among others!

TAVI challenges: session 3

Transfemoral TAVI access using intravascular lithotripsy in patients with challenging peripheral vascular disease

28 Nov 2022 – From PCR London Valves 2022

Watch this session to appreciate why it is better to tackle difficult transfemoral access rather than considering alternative access strategies and understand how intravascular lithotripsy mitigates procedural risk.

Transfemoral TAVI access

Contemporary best clinical practice for TAVI

28 Nov 2022 – From PCR London Valves 2022

Watch this case-based presentation to learn how to choose the right valve for the individual patient and how patient-tailored valve implantation techniques may optimise long-term outcomes.

Contemporary best clinical

TAVI in complex situations - LIVE case

28 Nov 2022 – From PCR London Valves 2022

  • Part 1: TAVI with the presence of a mechanical mitral valve.
    An 80-year-old female with a history of mechanical mitral valve (25 On-X in 2015) presents severe symptomatic AS with preserved LV function. The operators implant a 25 mm Navitor, with predilatation (18 mm balloon) on wire pacing...
Transcatheter intervention for aortic valve disease: state of the art

Rapid-Fire clinical cases: Session 3

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of clinical cases presented during PCR LV 2022: tunnel stent technique as an alternative treatment for left main protection in valve-in-valve TAVI, coronary embolisation due to valve-in-valve aortic prothesis thrombosis, aortic prosthetic valve dysfunction due to endocarditis, and more!

Rapid-Fire clinical cases: Session 3

Rapid-fire clinical cases: Session 4

28 Nov 2022 – From PCR London Valves 2022

Consult this session to discover a selection of abstracts presented during PCR LV 2022: the buddy wire technique used with three different transcatheter heart valve systems, acute right coronary artery occlusion caused by calcium embolisation during TAVI, off-label temporary left ventricle haemodynamic support via Impella CP...

Rapid-fire clinical cases: Session 4

Clinical outcomes after TAVI: Session 1

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about clinical outcomes after TAVI thanks to a selection of abstracts submitted during PCR LV 2022: definition of transcatheter heart valve orientation in bicuspid aortic valve with the DA VINCI study, TAVI with latest device iterations in patients with very...

Clinical outcomes after TAVI: Session 1

Therapy of valvular heart diseases: a patient-centred innovation journey

27 Nov 2022 – From PCR London Valves 2022

Join a team of experts as they review together the complete spectrum of valvular heart disease and ways in which we can manage it using emerging novel technologies.

Therapy of valvular heart

Create the future of TAVI - Optimisation of the procedure and patient pathway

27 Nov 2022 – From PCR London Valves 2022

Dive into this session to discover what can be improved today to be ready to treat future TAVI patient volumes. You'll also learn how to set up a successful TAVI coordinating team and adopt it in your hospital, and how to create a win-win partnership with...

Create the future of

TAVI: vascular access and bleeding complications

27 Nov 2022 – From PCR London Valves 2022

To learn more about FAST ACCESS Pilot, transfemoral-only TAVI, next-generation suture-mediated closure device in TAVR, or percutaneous axillary TAVI under local anaesthesia, among others, watch this session from PCR LV 2022!

TAVI: vascular access and bleeding complications

Paravalvular leak closure

27 Nov 2022 – From PCR London Valves 2022

5 specific cases are proposed in this PCR LV 2022 session dedicated to PVL, including concomitant ViV TAVI and paravalvular leak closure, transapical mitral paravalvular leak closure in a young patient, or transcatheter mitral ViV implantation for paravalvular leak. Watch the videos now to find out more!

Paravalvular leak closure